← USPTO Patent Applications

ENDOGLIN ANTIBODIES AND USES THEREOF

Application US20260086096A1 Kind: A1 Mar 26, 2026

Inventors

Nam Yong Lee

Abstract

This disclosure provides methods and compositions for detecting splice variants of the endoglin protein, enabling the accurate diagnosis of cancer. Additionally, the use of endoglin-specific antibodies enhances the detection process, offering a more precise and reliable approach to identifying cancer-related variants of endoglin.

CPC Classifications

G01N 33/5759 C07K 16/2896 G01N 33/543 G01N 33/57515 G01N 33/57525 G01N 33/57535 C07K 2317/14 G01N 2333/70596

Filing Date

2025-09-26

Application No.

19341471